Cardiff Oncology, Inc.
CRDF · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$45,431 | -$41,441 | -$38,704 | -$28,291 |
| Dep. & Amort. | $404 | $398 | $236 | $451 |
| Deferred Tax | $0 | $0 | $0 | $1,323 |
| Stock-Based Comp. | $4,760 | $4,509 | $4,256 | $3,234 |
| Change in WC | $3,172 | $6,568 | -$380 | -$1,789 |
| Other Non-Cash | -$598 | -$921 | $772 | $2,032 |
| Operating Cash Flow | -$37,693 | -$30,887 | -$33,820 | -$23,040 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$80 | -$582 | -$892 | -$205 |
| Net Acquisitions | $0 | $0 | -$114 | $205 |
| Inv. Purchases | -$23,563 | -$70,084 | -$91,233 | -$174,385 |
| Inv. Sales/Matur. | $37,371 | $106,861 | $130,274 | $43,142 |
| Other Inv. Act. | $0 | $0 | $114 | -$205 |
| Investing Cash Flow | $13,728 | $36,195 | $38,149 | -$131,448 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $53,407 | $0 | $75 | $34,187 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | -$414 | -$24 |
| Other Fin. Act. | $373 | $0 | $414 | $1,287 |
| Financing Cash Flow | $53,780 | $0 | $75 | $35,450 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $29,815 | $5,308 | $4,404 | -$119,038 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,655 | $16,347 | $11,943 | $130,981 |
| End Cash | $51,470 | $21,655 | $16,347 | $11,943 |
| Free Cash Flow | -$37,773 | -$31,469 | -$34,712 | -$23,245 |